Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries

Posted on by

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 11 Apr 2020)

 

Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
Respiratory syncytial virus (RSV) frequently causes acute lower respiratory infection in children under 5, representing a high burden in Gavi-eligible countries (mostly low-income and lower-middle-income). Sin…
Authors: Xiao Li, Lander Willem, Marina Antillon, Joke Bilcke, Mark Jit and Philippe Beutels
Citation: BMC Medicine 2020 18:82
Content type: Research article
Published on: 6 April 2020